Trevena Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Thank you, everyone, and welcome to day 2 of Oppenheimer's Fall Healthcare and Life Sciences Summit. This is Jeff Jones. I am Senior Analyst here at Oppenheimer in our healthcare equity research group. And today, I'd like to welcome Carrie Bourdow and Barry Shin, CEO and CFO of Trevena. Looking forward to getting an update from you guys on all that's been going on this fall. So with that, I will hand it over. Take us away, Carrie.
Great. Thank you, Jeff. Thank you for inviting us to the conference. We are excited to provide an update as well. So as Jeff mentioned, I am Carrie Bourdow. I am the President and CEO of Trevena.
I will be making forward-looking statements. I encourage you to review our regulatory filings. It's an important slide for us to present.
So Trevena is a CNS-focused company with an innovative pipeline. We have also a platform technology that is important for us to highlight. The technology came out of Duke University, and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |